Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

Maria Luisa Visciano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Luigi Buonaguro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Morgane Bomsel(Centre National de la Recherche Scientifique), V. Asti(Vita-Salute San Raffaele University), Maria Lina Tornesello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Lorenzo Diomede(Vita-Salute San Raffaele University), Lucia Lopalco(Vita-Salute San Raffaele University), Maria Tagliamonte(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Vaccine
May 22, 2011
10.1016/j.vaccine.2011.05.005
Cited by 42

Related Papers

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
|Infectious Agents and Cancer|2009|457
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
|The Lancet Infectious Diseases|2018|415
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
|Molecules|2020|375
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285